glp-1 study Real-World Evidence for Receptor Agonists Across the CKD Spectrum – AJKD Blog GLP1 agonists: current and future

Your first-month summary should include Medication name and dose Dose dates and times Any late or missed doses Injection sites used Weight trend (and body composition if measured) Top side effects with severity and timing Constipation or diarrhea pattern Protein, fiber, and water averages Foods that consistently helped or hurt Resistance-training and walking sessions completed Energy, sleep, mood concerns Questions you want answered Labs and screens to ask about at follow-up A1C and fasting glucose (if diabetic or prediabetic) Lipid panel Liver enzymes and kidney function Body composition recheck (DEXA or InBody) if available Iron, B12, vitamin D especially if you notice fatigue or hair shedding Mental health check-in note any persistent or severe changes in mood, sleep, or anxiety Whether to step the dose up, hold, or pause That is the value of first-month tracking: fewer vague memories, better clinician conversations, and more confidence in what changed

Adverse gastrointestinal effects of arginine and related amino acids

doi:10.1016/j.biocon.2003.07.002

Timed to sleep: when taken before bed, it lines up with your natural nighttime GH surge